Drug Profile
PRT 002
Alternative Names: PRT002Latest Information Update: 18 Dec 2015
Price :
$50
*
At a glance
- Originator Particle Therapeutics
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 18 Dec 2015 Discontinued - Preclinical for Undefined indication in United Kingdom (Intradermal)